MAM
Cristiano Ronaldo’s CR7 brand to enter India
Mumbai: Football player Cristiano Ronaldo’s Innerwear brand – CR7 – is set to launch in India.
CR7 offers luxury, fashion and basic innerwear ranges for men and boys. Designed in collaboration with New York-based designer Richard Chai who was voted as menswear designer of 2010 by the Council of Fashion Designers of America.
Commenting on the decision to enter India looking at the potential of this market, Michael Brandspoke director Michael Pike said, “The Cristiano Ronaldo CR7 offers a fabulous opportunity for the India market. It‘s an example of a global megastar wishing to engage the sports crazy nation, and its brand savvy consumers. Football is growing in popularity in India especially amongst the youth. CR7 is all set to create a niche for itself in the market for innerwear.”
Speaking on CR7 brand, Cristiano Ronaldo said, “The companies that I choose to work with need to be fashion oriented and of the highest quality to be able to deliver a superior product to my fans. In JBS, I have found a collaborator who produces products of the highest quality, and have a strong heritage of great design.”
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
